Dr James MacKean
/content/dam/genesiscare/headshots/au-doctor-headshots/AU_Oncology_Headshot_GA_Dr James MacKean.jpg
Radiation Oncologist

Dr James MacKean

Dr James MacKean
James
MacKean

MBBS, FRANZCR, Radiation Oncologist

For patients/carers

For doctors

MBBS, FRANZCR, Radiation Oncologist

Locations

Wesley Medical Centre (Auchenflower), QLD
Wesley Medical Centre (Auchenflower)
The Wesley Medical Centre, 1/40 Chasely St, Auchenflower, QLD, 4066, Australia
-27.476494536119898, 152.99746445565626
/au/our-centres/wesley-hospital
QLD
Chermside, QLD
Chermside
Chermside Medical Complex, Lower Ground Floor, 956 Gympie Road, Chermside, QLD, 4032, Australia
-27.381837593738126, 153.02949042694252
/au/our-centres/chermside
QLD
Rockhampton (Central Queensland), QLD
Rockhampton (Central Queensland)
Rockhampton Hospital, Lower Ground Floor, Canning Street, Rockhampton, QLD, 4700, Australia
-23.384346304606563, 150.49969726890262
/au/our-centres/rockhampton-oncology
QLD

Languages

Fluent

  • English

Biography

Clinical interests in prostate, urological, and gastrointestinal cancers, haematology, palliative radiation therapy, and clinical mentoring.

Dr James MacKean is based in Brisbane and works at both GenesisCare’s Chermside and Wesley centres. James also regularly visits GenesisCare Rockhampton and attends the Gladstone Outreach Clinic monthly.

James was awarded the Windeyer Fellowship in 1999. He completed registrar training in New South Wales and a Fellowship year at Mt Vernon Hospital, London before commencing employment at The Wesley in 2000.He has a particular interest in all aspects of the management of Prostate cancer.

His other interests are Palliative radiation therapy, Colorectal and Haematological malignancies. He is a member of the Faculty of Radiation Oncology Genito-urinary Group and a former chair of the Australasian Brachytherapy Group.

More information

Professional memberships
  • Fellow RANZCR
Publications
  • Long‐term outcomes of high‐dose‐rate brachytherapy for intermediate‐ and high‐risk prostate cancer with a median follow‐up of 10 years.  John W. Yaxley Kevin V2Lah  Julian P. Yaxley  Robert A. Gardiner  Hema Samaratunga  James MacKean, BJUI,vol120, 2017 , p 56-60